What type of study is this?

Clinical Investigations of High-Risk Medical Devices in India, Germany and Canada

View Full Paper

Ask AI

Bookmark

Authors

Qualitative study examines regulatory frameworks and clinical evidence for high-risk devices in three countries, highlighting common challenges.

Results reveal that India faces significant infrastructure gaps despite regulatory progress in high-risk device oversight.
Germany's rigorous clinical evidence requirements are challenged by bottlenecks and compliance fatigue in the regulatory process.
Canada's balanced oversight is innovative but faces trial efficiency issues due to high costs and provincial fragmentation.
Shared challenges across countries include regulatory ambiguity and incomplete post-market surveillance systems.

Ansitha et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Qualitative study examines regulatory frameworks and clinical evidence for high-risk devices in three countries, highlighting common challenges.